Semaglutide is primarily used to help with weight loss and to manage blood sugar levels in people with diabetes
Friday, the FDA reclassified the semaglutide shortagewhich had covered multiple doses of Wegovy for obesity and Ozempic for Type 2 diabetesas "resolved" on its online drug shortage database
PlexusDx's Precision Peptide Genetic Test can identify inherited variations in other peptide-pathway genes that may predispose you to stronger gastrointestinal responses, helping your provider adjust your starting dose or escalation schedule accordingly
Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)